Element Materials Technology Acquires Arch Sciences Group

July 20, 2021

Element Materials Technology, a London-headquartered testing, inspection and certification provider, has acquired Arch Sciences Group, a specialist analytical services and laboratory solutions provider to the pharmaceuticals sector. The deal (which sees Limerston Capital exit its investment in Arch) brings Element a team of ~170 employees across five locations and establishes Element's entry into the European pharmaceutical market, expanding its life sciences capabilities.

Targets
Arch Sciences Group
Sellers
Limerston Capital
Industry
Pharmaceuticals
Location
England, United Kingdom
Transaction Type
Buyout

Explore More

Build a buyer list for your deal

Find active buyers from recent acquisition patterns and move straight into outreach.